Concurrent suppression of Aβ aggregation and NLRP3 inflammasome activation for treating Alzheimer's disease

Alzheimer's disease (AD) is a neurodegenerative illness accompanied by severe memory loss, cognitive disorders and impaired behavioral ability. Amyloid β-peptide (Aβ) aggregation and nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome play crucial roles...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tao, Zhang, Lei, Shang, Yicun, Zhu, Zhenzhu, Jin, Suxing, Guo, Zijian, Wang, Xiaoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905858/
https://www.ncbi.nlm.nih.gov/pubmed/35382471
http://dx.doi.org/10.1039/d1sc06071f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905858/
https://www.ncbi.nlm.nih.gov/pubmed/35382471
http://dx.doi.org/10.1039/d1sc06071f

Ejemplares similares